PCC = Pennsylvania Convention Center ASRM 75TH SCIENTIFIC CONGRESS • SCHEDULE AT A GLANCE Simultaneous live Spanish and Mandarin Chinese Translations of all MONDAY, OCTOBER 14, 2019 Lectures and Symposia in Exhibit Hall C TIME LOCATION ACTIVITY/PRESENTERS 7:00 am – 7:45 am PCC Exhibit Hall C Hallway Opening Ceremony Continental Breakfast 7:45 am - 8:30 am PCC Exhibit Hall C Opening Ceremony 8:30 am - 9:15 am PCC Exhibit Hall C Plenary Lecture 1: President’s Guest Lecture: Closing the Generational Gap Between Practitioners and Patients (Ryan Jenkins) 9:15 am - 10:00 am PCC Exhibit Hall C Plenary Lecture 2: Camran Nezhat, M.D. Lectureship in Innovations in Medicine: Using Live Imaging to Reveal the Mechanisms that Form the Mammalian Embryo (Nicholas Plachta, Ph.D.) 10:00 am - 10:45 am PCC Expo Hall Break – Visit the Expo Hall 10:45 am - 12:15 pm Oral Abstract Sessions PCC Exhibit Hall C PP01 SCIENTIFIC CONGRESS PRIZE PAPER SESSION 1 PCC 104B OR01-05 ENVIRONMENT AND REPRODUCTION SPERM ASPIRATION (MIESA) RESULTS IN NON-INFERIOR IVF 10:45 AM O-1 ANTIDEPRESSANT MEDICATION EXPOSURE: 10:45 AM O-31 EFFECT OF WILDFIRE SMOKE ON PREGNANCY OUTCOMES COMPARED WITH NORMAL EJACULATED SEMEN IN TIME TO PREGNANCY AND RISK OF PREGNANCY LOSS. L. A. Sjaarda OUTCOMES IN THE NON-HUMAN PRIMATE. B. E. Willson COUPLES WITH UNEXPLAINED INFERTILITY. S. Hayon 11:00 AM O-2 EFFECTS OF FOLIC ACID AND ZINC 11:00 AM O-32 STRESS AND SUCCESS: DATA FROM A 11:45 AM O-59 GONADAL END ORGAN EFFECTS IN MALE TO SUPPLEMENTATION IN MEN ON SEMEN QUALITY AND LIVE BIRTH PROSPECTIVE COHORT INVESTIGATING THE IMPACT OF EARLY LIFE FEMALE TRANSGENDER PATIENTS ON HORMONAL THERAPY. AMONG COUPLES UNDERGOING INFERTILITY TREATMENT: FINDINGS STRESS ON IVF OUTCOMES. J. R. Walter P. Bearelly FROM THE FAZST RANDOMIZED TRIAL. E. F. Schisterman 11:15 AM O-33 PESTICIDE RESIDUE INTAKE FROM FRUIT AND 12:00 PM O-60 THE UTILITY OF SPERM CRYOPRESERVATION AT 11:15 AM O-3 CAN HYSTEROSALPINGO FOAM SONOGRAPHY VEGETABLE CONSUMPTION AND RISK OF LAPAROSCOPICALLY- THE TIME OF VASECTOMY REVERSAL. J. A. Marinaro (HYFOSY) REPLACE HYSTEROSALPINGOGRAPHY (HSG) AS FIRST CONFIRMED ENDOMETRIOSIS. H. Harris PCC 113B OR01-10 NUTRITION CHOICE TUBAL PATENCY TEST: A RANDOMIZED COMPARISON (FOAM 11:30 AM O-34 BLOOD CADMIUM ASSOCIATED WITH HIGHER 10:45 AM O-61 PRECONCEPTION MARIJUANA USE, STUDY)? N. van Welie TESTOSTERONE AND ANTI-MÜLLERIAN HORMONE IN HEALTHY ANOVULATION, AMH, AND PREGNANCY OUTCOMES. S. L. Mumford 11:30 AM O-4 MALE MARIJUANA USE AND SPONTANEOUS PREMENOPAUSAL WOMEN. K. Kim 11:00 AM O-62 SERUM OMEGA-3 AND OMEGA-6 FATTY ACID ABORTION. A. F. Harlow 11:45 AM O-35 THE ASSOCIATION OF URINARY CONCENTRATIONS AND FECUNDITY. J. Stanhiser 11:45 AM O-5 BEETROOT, WATERMELON AND GINGER JUICE CONCENTRATIONS OF BISPHENOL-A, AND DI-ETHYLHEXYL 11:15 AM O-63 THE ROLE OF MATERNAL PRECONCEPTION SUPPLEMENTATION MAY INCREASE THE CLINICAL OUTCOMES OF PHTHALATE METABOLITES WITH THYROID FUNCTION & VITAMIN D STATUS IN HUMAN OFFSPRING SEX RATIO. INTRACYTOPLASMIC SPERM INJECTION CYCLES. D. P. Braga AUTOIMMUNITY IN WOMEN FROM A FERTILITY CENTER: RESULTS A. C. Purdue-Smithe 12:00 PM O-6 PHASE 3 TRIAL RESULTS: EFFICACY AND SAFETY FROM THE ENVIRONMENT AND REPRODUCTIVE HEALTH STUDY. 11:30 AM O-64 CAFFEINATED BEVERAGE INTAKE AND SERUM OF ELAGOLIX IN A SUBSET OF WOMEN WITH UTERINE FIBROIDS AND I. Souter CAFFEINE METABOLITES AND RISK OF PREGNANCY LOSS. ADENOMYOSIS. O. Muneyyirci-Delale 12:00 PM O-36 NON-CHRONIC PRECONCEPTION OPIOID USE A. C. Purdue-Smithe PCC 204A OR01-01 ART LAB: BASIC AND REPRODUCTIVE OUTCOMES. K. S. Flannagan 11:45 AM O-65 LEPTIN IS A MEDIATOR IN THE ASSOCIATION 10:45 AM O-7 IMPLEMENTATION OF AN ELECTRONIC PCC 111AB OR01-06 GENETIC COUNSELING BETWEEN PERCENT BODY FAT AND DECREASED AMH AMONG WHITEBOARD FOR QUALITY MANAGEMENT IN THE IN VITRO 10:45 AM O-37 LESSONS LEARNED FROM EVALUATING HEALTHY WOMEN. J. Aly FERTILIZATION LABORATORY. P. A. Romanski DECISIONAL REGRET SURROUNDING PREIMPLANTATION GENETIC 12:00 PM O-66 OMEGA-3 FATTY ACID SUPPLEMENTATION AND 11:00 AM O-8 THE CLINICAL RESULTS OF PIEZO-ICSI COMPARED TESTING FOR ANEUPLOIDY. A. Wijekoon FECUNDABILITY. J. Stanhiser TO CONVENTIONAL-ICSI: A SIBLING-OOCYTE STUDY. N. Okuyama 11:00 AM O-38 FOCUSING ON PARENTAL ORIGIN OF PCC 105AB OR01-11 OVARIAN STIMULATION 11:15 AM O-9 WOULD AN AUTOMATED SYSTEM DETECTING ANEUPLOIDY: DOES PATERNAL AGE IMPACT ANEUPLOIDY RATES IN 10:45 AM O-67 A COMPUTERIZED DECISION –SUPPORT SYSTEM EMBRYO DEVELOPMENTAL EVENTS SELECT THE SAME EMBRYO AS EMBRYOS? K. Merrion FOR DAY TO DAY MANAGEMENT OF OVARIAN STIMULATION CYCLES AN EMBRYOLOGIST USING A MORPHOKINETIC ALGORITHM? 11:15 AM O-39 DO BRCA MUTATIONS IMPACT ANEUPLOIDY DURING IN VITRO FERTILIZATION. G. S. Letterie R. Del Gallego RATES IN EMBRYOS? N. Wemmer 11:00 AM O-68 DUAL TRIGGERING OF FINAL OOCYTE 11:30 AM O-10 PROPORTION OF PATIENTS DETECTED WITH 11:30 AM O-40 THE TP53 GENE (rs1625895) C>T MATURATION IN POOR OVARIAN RESPONDERS: A PROSPECTIVE SUBCLINICAL HYPOTHYROIDISM IS INDEPENDENT OF TIME OF POLYMORPHISM IS ASSOCIATED WITH OVARIAN RESERVE AND RANDOMIZED CONTROLLED TRIAL. D. Khalife BLOOD DRAW. C. Briton-Jones OVARIAN RESPONSE TO RECOMBINANT FSH DURING IVF/ICSI 11:15 AM O-69 RISK OF HARM ASSOCIATED WITH THE USE OF 11:45 AM O-11 PRELIMINARY RESULTS FROM THE FIRST TREATMENT. J. A. Oliveira LETROZOLE AS A FERTILITY DRUG: A SYSTEMATIC REVIEW AND META- REGISTERED PILOT TRIAL WITH MATERNAL SPINDLE TRANSFER TO 11:45 AM O-41 NON-INVASIVE PRENATAL TESTING HAS ANALYSIS. J. Pundir OVERCOME INFERTILITY. N. Costa-Borges ALTERED POSITIVE PREDICTIVE VALUE FOLLOWING TRANSFER OF A 11:30 AM O-70 PREMATURE LUTEINIZATION IN THE ERA 12:00 PM O-12 EFFECT OF SPERM SELECTION USING MACS EUPLOID BLASTOCYST. A. M. Klimczak OF PGT-A: EMBRYONIC REPRODUCTIVE POTENTIAL IS NOT TECHNOLOGY IN THE PGT-A PROGRAM COMPARED WITH STANDARD 12:00 PM O-42 SONOGRAPHIC ABNORMALITIES IN AFFECTED BY ELEVATED PROGESTERONE LEVELS DURING OVARIAN SPERM PREPARATION. M. Meseguer PREGNANCIES CONCEIVED FOLLOWING IVF WITH AND WITHOUT HYPERSTIMULATION. C. Hernandez-Nieto PCC 103A OR01-02 ART OFFSPRING PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY. 11:45 AM O-71 DETERMINING CORRELATION BETWEEN BODY 10:45 AM O-13 THIRD GRADE ACADEMIC ACHIEVEMENT AMONG C. Riestenberg MASS INDEX AND MINIMUM REQUIRED HCG DOSE WHEN USING CHILDREN CONCEIVED WITH IVF: A POPULATION-BASED STUDY IN PCC 103B OR01-07 HEALTH DISPARITIES DUAL TRIGGER WITH HCG AND GnRH AGONIST. L. D. Zimmerman TEXAS. B. Luke 10:45 AM O-43 COMPARISON OF EUPLOID RATES VIA 12:00 PM O-72 EFFECT OF DEHYDROEPIANDROSTERONE 11:00 AM O-14 SEX DIFFERENCES IN BIRTH OUTCOMES FOR PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) (DHEA) SUPPLEMENTATION ON INTRACYTOPLASMIC SPERM MASSACHUSETTS INFANTS FOLLOWING ART. S. S. Hwang AND SUBSEQUENT PREGNANCY OUTCOMES BETWEEN ASIAN AND INJECTION OUTCOME IN INFERTILE WOMEN WITH ANTICIPATED 11:15 AM O-15 CONCEPTION BY INFERTILITY TREATMENT AND WHITE PATIENTS. D. Huang NORMO-OVARIAN RESPONSE. A. M. Abbas NEWBORN DNA METHYLATION. E. Yeung 11:00 AM O-44 INTERSECTION OF SEXUALLY TRANSMITTED PCC BALLROOM AB OR01-12 PREIMPLANTATION GENETIC TESTING 11:30 AM O-16 BABIES BORN FOLLOWING ADMINISTRATION OF INFECTIONS AND SUBSTANCE USE AMONG LOW-INCOME MINORITY 10:45 AM O-73 PGT FOR ANEUPLOIDY IMPROVES PERINATAL NOLASIBAN BEFORE EMBRYO TRANSFER (ET) AFTER IVF: NEONATAL WOMEN: ROUTINE CARE AS A CRITICAL POINT FOR REDUCING OUTCOMES COMPARED WITH FET ALONE: AN ANALYSIS OF THE 2014 AND INFANT DEVELOPMENT OUTCOMES FROM A DOUBLE-BLIND, REPRODUCTIVE HEALTH DISPARITIES. T. McClung AND 2015 SART DATA. K. Van Heertum PLACEBO-CONTROLLED, CLINICAL TRIAL. E. Loumaye 11:15 AM O-45 ANTI-MÜLLERIAN HORMONE (AMH) 11:00 AM O-74 DOES PREIMPLANTATION GENETIC TESTING 11:45 AM O-17 SIMILAR SUCCESS RATES WITH FROZEN TRAJECTORIES IN REPRODUCTIVE AGED AFRICAN-AMERICAN FOR ANEUPLOIDY (PGT-A) HARM EMBRYOS? NO—A MULTI-CENTER, OOCYTES BUT INCREASED RATE OF LARGE FOR GESTATIONAL AGE WOMEN: FINDINGS FROM THE STUDY OF OVARIAN AGING AND PROSPECTIVE, BLINDED, NON-SELECTION STUDY EVALUATING THE (LGA) INFANTS COMPARED TO FRESH OOCYTES. C. Burks RESERVE (SOAR). E. Giuliani PREDICTIVE VALUE OF AN ANEUPLOID DIAGNOSIS AND IMPACT OF 12:00 PM O-18 PREVALENCE OF CLINICALLY SIGNIFICANT 11:30 AM O-46 PERSISTENT WIDENING IN RACIAL DISPARITIES BIOPSY A. W. Tiegs CONGENITAL HEART DEFECTS IN LOW-RISK IVF PREGNANCIES. S. H. BETWEEN BLACK AND WHITE WOMEN UNDERGOING ART OVER THE 11:15 AM O-75 PREIMPLANTATION GENETIC TESTING (PGT) IS Bjorkman LAST 10 YEARS. A. Kotlyar ASSOCIATED WITH HIGHER ODDS OF A HEALTHY LIVEBIRTH AMONG PCC 106B OR01-03 CONTRACEPTION AND COMPLEX FAMILY PLANNING 11:45 AM O-47 SOUTH ASIAN WOMEN HAVE POORER IVF DONOR OOCYTE RECIPIENTS IN THE UNITED STATES: A 2013-2015 10:45 AM O-19 TOPICAL LIDOCAINE-PRILOCAINE CREAM VERSUS OUTCOMES DESPITE BEING YOUNGER AND HAVING BETTER NATIONAL STUDY. C. Roeca LIDOCAINE 1% SUBCUTANEOUS INFILTRATION DURING NEXPLANON OVARIAN RESERVE COMPARED TO CAUCASIANS. F. I. Sharara 11:30 AM O-76 PREGNANCY OUTCOMES FOLLOWING IN VITRO INSERTION: A RANDOMIZED CONTROLLED STUDY. A. M. Abbas 12:00 PM O-48 REGIONAL DISPARITIES IN ASSISTED FERTILIZATION FROZEN EMBRYO TRANSFER (IVF-FET) WITH OR 11:00 AM O-20 A RANDOMIZED CLINICAL TRIAL BETWEEN REPRODUCTIVE TECHNOLOGY ACCESS TO CARE: EMPLOYING WITHOUT PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY ULTRASOUND-GUIDED AND UTERINE SOUND-SPARING APPROACH MODERN TECHNOLOGY TO CLOSE THE GAP. S. Mikhael (PGT-A) IN WOMEN WITH RECURRENT PREGNANCY LOSS (RPL): A FOR COPPER INTRAUTERINE DEVICE INSERTION. A. M. Abbas PCC 103C OR01-08 INFERTILITY AND CANCER SART-CORS STUDY. S. Bhatt 11:15 AM O-21 EFFECT OF CELL-PHONE ASSISTED 10:45 AM O-49 PREGNANCIES IN CANCER SURVIVORS: OVARIAN 11:45 AM O-77 CONCURRENT PRE-IMPLANTATION GENETIC POSTPARTUM COUNSELING ON THE USE OF LONG-ACTING RESERVE IS A POOR PROGNOSTICATOR.